allergan.comAllergan: A Bold, Global Pharmaceutical Company
allergan.com Profile
allergan.com
Sub Domains:epgateway-ca.allergan.com epgateway.allergan.com
Title:Allergan: A Bold, Global Pharmaceutical Company
Description:Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.
Discover allergan.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
allergan.com Information
Website / Domain: |
allergan.com |
HomePage size: | 98.198 KB |
Page Load Time: | 0.344968 Seconds |
Website IP Address: |
52.52.3.152 |
Isp Server: |
E.I. du Pont de Nemours and Co. Inc. |
allergan.com Ip Information
Ip Country: |
United States |
City Name: |
Wilmington |
Latitude: |
39.749801635742 |
Longitude: |
-75.554298400879 |
allergan.com Keywords accounting
allergan.com Httpheader
Cache-Control: no-cache, no-store |
Pragma: no-cache |
Content-Length: 19459 |
Content-Type: text/html; charset=utf-8 |
Content-Encoding: gzip |
Expires: -1 |
Vary: Accept-Encoding |
Set-Cookie: ASP.NET_SessionId=t2zk4isi032kpvqdykm3u25z; path=/; secure; HttpOnly; SameSite=Lax, SC_ANALYTICS_GLOBAL_COOKIE=b6f4a9539bd6440d9b5f23536c94c538|False; expires=Tue, 29-Jan-2030 03:37:00 GMT; path=/; secure; HttpOnly, sxa_site=us; path=/; secure; HttpOnly, ARRAffinity=dc5ae3a07547a86cc44690165a56c0c39dfa24c118f982d37f22b06427a75573;Path=/;HttpOnly;Domain=www.allergan.com |
X-UA-Compatible: IE=Edge |
Date: Sat, 01 Feb 2020 03:37:01 GMT |
allergan.com Meta Info
charset="utf-8"/ |
content="initial-scale=1.0, width=device-width" name="viewport"/ |
content="Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. " name="description" |
content="width=device-width, initial-scale=1" name="viewport"/ |
52.52.3.152 Domains
allergan.com Similar Website
Domain |
WebSite Title |
reprosrx.com | Allergan: A Bold, Global Pharmaceutical Company |
allergan.com | Allergan: A Bold, Global Pharmaceutical Company |
endo.com | Endo | A Global Specialty Pharmaceutical Company |
store.humco.com | Humco A Diversified Global Pharmaceutical Company |
go.capsugel.com | Global Pharmaceutical Dosage Solutions Company | Capsugel |
capsugel.com | Global Pharmaceutical Dosage Solutions Company | Capsugel |
interhealthusa.com | Global Pharmaceutical Dosage Solutions Company | Capsugel |
medpharma.pharmaceuticalconferences.com | Med Pharma Congress 2020 | Pharmaceutical Events | Medicinal Conferences | Pharmaceutical Conference |
mobile.in-pharmatechnologist.com | Pharmaceutical news, Pharma industry, Pharmaceutical manufacturing |
in-pharmatechnologist.com | Pharmaceutical news, Pharma industry, Pharmaceutical manufacturing |
mallinckrodt.com | Mallinckrodt Pharmaceuticals | Global Specialty Pharmaceutical Company | Mallinckrodt Pharmaceutic |
neworleans.boldtypetickets.com | Find Events Buy Tickets Bold Type - Bold Type Tickets |
investor.frx.com | Investors - Allergan |
research.pharmaceuticalconferences.com | Pharma Conferences | Pharmaceutical Research Conferences 2020| Pharmaceutical Sciences Meetings: Bi |
brilliantdistinctionsprogram.com | Brilliant Distinctions® by Allergan® |
allergan.com Traffic Sources Chart
allergan.com Alexa Rank History Chart
allergan.com Html To Plain Text
'); Global Sites Countries Country Sites Countries Country Sites Argentina Argentina Site Australia Australia Site Austria Austria Site Bahrain Bangladesh Barbados Belgium Belgium Site Bolivia Brazil Brazil Site Canada Canada Site Chile Chile Site China (Mainland) China (Mainland) Site Colombia Colombia Site Costa Rica Czech Republic Czech Republic Site Denmark Dominican Republic Ecuador Egypt El Salvador Finland France France Site Germany Germany Site Greece Guatemala Honduras Hong Kong (China) Hungary India India Site Indonesia Ireland Ireland Site Israel Italy Italy Site Jamaica Japan Japan Site Jordan Korea Korea Site Kuwait Lebanon Malaysia Mexico Mexico Site Netherlands Netherlands Site New Zealand New Zealand Site Norway Pakistan Palestine Panama Peru Philippines Poland Poland Site Portugal Portugal Site Puerto Rico Romania Russia Russia Site Saudi Arabia Serbia Serbia Site Singapore Slovakia South Africa South Africa Site Spain Spain Site Sri Lanka Sweden Sweden Site Switzerland Switzerland Site Taiwan (China) Taiwan (China) Site Thailand Trinidad & Tobago Turkey Turkey Site Ukraine United Arab Emirates United Kingdom United Kingdom Site United States United States Site Uruguay Venezuela Vietnam Yemen Global / USA Investors Careers Contact Products Key Therapeutic Areas Central Nervous System Key Products BOTOX® (onabotulinumtoxinA) Product Details BOTOX® (onabotulinumtoxinA) For Providers Prescribing Information, including Boxed Warning Medication Guide Safety Data Sheet For Patients Patient Assistance Program botox.com NAMZARIC® (memantine hydrochloride extended-release and donepezil hydrochloride) capsules, for oral use Product Details NAMZARIC® (memantine hydrochloride extended-release and donepezil hydrochloride) capsules, for oral use For Providers Prescribing Information Safety Data Sheet For Patients Patient Assistance Program namzaric.com VRAYLAR® (cariprazine) capsules, for oral use Product Details VRAYLAR® (cariprazine) capsules, for oral use For Providers Prescribing Information, including Boxed Warnings Safety Data Sheet For Patients Patient Assistance Program vraylar.com All Central Nervous System Products Eye Care Key Products LUMIGAN® 0.01% (bimatoprost ophthalmic solution 0.01%) Product Details LUMIGAN® 0.01% (bimatoprost ophthalmic solution 0.01%) For Providers Prescribing Information For Patients Patient Assistance Program lumigan.com OZURDEX® (dexamethasone intravitreal implant) 0.7 mg Product Details OZURDEX® (dexamethasone intravitreal implant) 0.7 mg For Providers Prescribing Information Safety Data Sheet ozurdex.com REFRESH® Portfolio of Consumer Eye Care Products Product Details REFRESH® Portfolio of Consumer Eye Care Products refreshbrand.com All Eye Care Products Gastroenterology Key Products LINZESS® (linaclotide) capsules, for oral use Product Details LINZESS® (linaclotide) capsules, for oral use For Providers Prescribing Information, including Boxed Warning Safety Data Sheet For Patients Patient Assistance Program linzess.com VIBERZI® (eluxadoline) tablets, for oral use, CIV Product Details VIBERZI® (eluxadoline) tablets, for oral use, CIV For Providers Prescribing Information Safety Data Sheet For Patients Patient Assistance Program viberzi.com ZENPEP® (pancrelipase) delayed release capsules Product Details ZENPEP® (pancrelipase) delayed release capsules For Providers Prescribing Information Safety Data Sheet For Patients Patient Assistance Program zenpep.com All Gastroenterology Products Medical Aesthetics Key Products BOTOX® Cosmetic (onabotulinumtoxinA) Product Details BOTOX® Cosmetic (onabotulinumtoxinA) For Providers Prescribing Information, including Boxed Warning Medication Guide Safety Data Sheet botoxcosmetic.com COOLSCULPTING® Product Details COOLSCULPTING® coolsculpting.com JUVÉDERM® Ultra Product Details JUVÉDERM® Ultra For Providers Directions for Use For Patients Patient Labeling juvederm.com SkinMedica® Product Details SkinMedica® skinmedica.com All Medical Aesthetics Products Patient Assistance Programs View All Products About About Allergan About Allergan News Executive Leadership Business Development Supplier Relations Patent Notices Media Resources Allergan For Patients & Caregivers Healthcare Providers Investors Careers R&D R&D Pipeline Clinical Trials Innovation Pre-Approval Access Responsibility Responsibility at Allergan Community Environmental & Sustainability Social Contract Patient Safety & Product Quality Healthcare Provider Partnerships & Payments Alliance Advocacy Support Public Policy California Supply Chain Disclosure Menu Close Global / USA Home Products Key Therapeutic Areas Central Nervous System Eye Care Gastroenterology Medical Aesthetics Patient Assistance Programs View All Products About About Allergan About Allergan News Executive Leadership Business Development Supplier Relations Patent Notices Media Resources R&D R&D Pipeline Clinical Trials Innovation Pre-Approval Access Responsibility Responsibility at Allergan Community Environmental & Sustainability Social Contract Patient Safety & Product Quality Healthcare Provider Partnerships & Payments Alliance Advocacy Support Public Policy California Supply Chain Disclosure Investors Media Patients Providers Careers Contact Central Nervous System Key Products View All Central Nervous System Products BOTOX® (onabotulinumtoxinA) NAMZARIC® (memantine hydrochloride extended-release and donepezil hydrochloride) capsules, for oral use VRAYLAR® (cariprazine) capsules, for oral use Eye Care Key Products View All Eye Care Products LUMIGAN® 0.01% (bimatoprost ophthalmic solution 0.01%) OZURDEX® (dexamethasone intravitreal implant) 0.7 mg REFRESH® Portfolio of Consumer Eye Care Products Gastroenterology Key Products View All Gastroenterology Products LINZESS® (linaclotide) capsules, for oral use VIBERZI® (eluxadoline) tablets, for oral use, CIV ZENPEP® (pancrelipase) delayed release capsules Medical Aesthetics Key Products View All Medical Aesthetics Products BOTOX® Cosmetic (onabotulinumtoxinA) COOLSCULPTING® JUVÉDERM® Ultra SkinMedica® Investors Investors Events & Presentations Corporate & Financial Information Corporate Information: Executives & Leadership Corporate Governance Committee Composition Committee Charters Acquisition of Allergan by AbbVie Financials: Annual Reports Quarterly Results SEC Filings Insider Transactions Proxy Materials Shareholder Resources Shareholder Services & Investor Kit Information Request Form Email Alerts Dividends Investor FAQ Stock information Stock Information Stock Information Historic Stock Look-Up Analyst Coverage Investment Calculator Media Media Company Profile Executive Bios & Photos images Videos Patients Patients Providers Providers Medical Information Request Careers Careers Search Careers Live Boldly Watch video Allergan For Patients & Caregivers Healthcare Providers Your Career Investors Play Video Stop Video Mute Video Unmute Video Close Video Acquisition of Allergan plc by AbbVie Inc. BIOCELL® Product Safety Alert Featured Allergan Donates ¥1 Million to Aid China in the Fight Against Coronavirus More News Allergan to Report Fourth Quarter and Full Year 2019 Financial Results Announcement under the Irish Takeover Rules: Relevant Securities in Issue - January 30, 2020 AbbVie and Allergan Announce Agreements to Divest Brazikumab and Zenpep About Allergan All Products Contact Compliance Privacy Terms California Privacy Sitemap Copyright © 2020 Allergan X This website uses cookies and other technologies to personalize content and to show you more personalized ads (for example, Google Ads and Facebook) on this and other websites, as well as provide you with social media features on this website (such as, Facebook, Twitter, LinkedIn). By clicking “Accept” you understand that you are directing Allergan to disclose your personal information, including internet tracking data (like cookies and the IP address you used to access...
allergan.com Whois
"domain_name": [
"ALLERGAN.COM",
"allergan.com"
],
"registrar": "MarkMonitor, Inc.",
"whois_server": "whois.markmonitor.com",
"referral_url": null,
"updated_date": [
"2017-04-14 16:57:16",
"2019-02-25 13:43:52-08:00"
],
"creation_date": [
"1994-07-14 04:00:00",
"1994-07-13 21:00:00-07:00"
],
"expiration_date": [
"2020-07-13 04:00:00",
"2020-07-13 00:00:00-07:00"
],
"name_servers": [
"HA1.MARKMONITOR.ZONE",
"HA2.MARKMONITOR.ZONE",
"HA3.MARKMONITOR.ZONE",
"HA4.MARKMONITOR.ZONE",
"ha3.markmonitor.zone",
"ha2.markmonitor.zone",
"ha4.markmonitor.zone",
"ha1.markmonitor.zone"
],
"status": [
"clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited",
"clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited",
"clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited)",
"clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited)",
"clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited)"
],
"emails": [
"abusecomplaints@markmonitor.com",
"whoisrequest@markmonitor.com"
],
"dnssec": "unsigned",
"name": null,
"org": "Allergan, Inc.",
"address": null,
"city": null,
"state": "CA",
"zipcode": null,
"country": "US"